Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: Application to a pharmacokinetic study

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

Eminy H.Y. Lee, S RYAN, Bruce K. Birmingham et al. · Clinical Pharmacology & Therapeutics · 2005 · 477 citations

Medicine, Pharmacokinetics, Pharmacology +17

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

Anders Olsson, John Pears, John McKellar et al. · The American Journal of Cardiology · 2001 · 194 citations

Pharmacy, Cardiology, Pharmacotherapy +12

Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia

Anders Olsson, Helge Istad, O Luurila et al. · American Heart Journal · 2002 · 177 citations

Pharmacy, Cardiology, Pharmacotherapy +9

Pharmacodynamic effects and pharmacokinetics of a new HMG‐CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers

Paul Martin, Patrick Mitchell, Dennis W. Schneck · British Journal of Clinical Pharmacology · 2002 · 150 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Liver-Specific Distribution of Rosuvastatin in Rats: Comparison with Pravastatin and Simvastatin

Ken-ichi Nezasa, Kazutaka Higaki, Tadahiko Matsumura et al. · Drug Metabolism and Disposition · 2002 · 106 citations

Pharmacy, Pharmacokinetics, Pharmacology +14